Neural Regeneration Research ›› 2014, Vol. 9 ›› Issue (4): 430-435.doi: 10.4103/1673-5374.128255

Previous Articles     Next Articles

7.0T nuclear magnetic resonance evaluation of the amyloid beta (1–40) animal model of Alzheimer’s disease: comparison of cytology verification

Lei Zhang1, Shuai Dong2, Guixiang Zhao3, Yu Ma4   

  1. 1 MR Neuroradiology Room, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China
    2 Department of Neurology, Sixth People’s Hospital of Jinan, Jinan, Shandong Province, China
    3 Department of Rehabilitation Medicine, Sixth People’s Hospital of Jinan, Jinan, Shandong Province, China
    4 Tsinghua University Yuquan Hospital, Beijing, China
  • Received:2013-11-25 Online:2014-02-25 Published:2014-02-25
  • Contact: Yu Ma, M.D., Tsinghua University Yuquan Hospital, Beijing 100049, China, lymayu@163.com.
  • Supported by:

    This study was supported by the National Natural Science Foundation of China, No. 81141013; a grant for Talents in Beijing, No. 2011D003034000019.

Abstract:

3.0T magnetic resonance spectroscopic imaging is a commonly used method in the research of brain function in Alzheimer’s disease. However, the role of 7.0T high-field magnetic resonance spectroscopic imaging in brain function of Alzheimer’s disease remains unclear. In this study, 7.0T magnetic resonance spectroscopy showed that in the hippocampus of Alzheimer’s disease rats, the N-acetylaspartate wave crest was reduced, and the creatine and choline wave crest was elevated. This finding was further supported by hematoxylin-eosin staining, which showed a loss of hippocampal neurons and more glial cells. Moreover, electron microscopy showed neuronal shrinkage and mitochondrial rupture, and scanning electron microscopy revealed small size hippocampal synaptic vesicles, incomplete synaptic structure, and reduced number. Overall, the results revealed that 7.0T high-field nuclear magnetic resonance spectroscopy detected the lesions and functional changes in hippocampal neurons of Alzheimer’s disease rats in vivo, allowing the possibility for assessing the success rate and grading of the amyloid beta (1–40) animal model of Alzheimer’s disease.

Key words: nerve regeneration, Alzheimer’s disease, Aβ1–40, high-field functional magnetic resonance, nuclear magnetic resonance spectroscopy, neuropathology, N-acetylaspartate, creatine, choline, hippocampus, NSFC grant, neural regeneration